About The Drug Aci-Jel aka Vaginal Jelly
Find Aci-Jel side effects, uses, warnings, interactions and indications. Aci-Jel is also known as Vaginal Jelly.
Aci-Jel
About Aci-Jel aka Vaginal Jelly |
---|
What's The Definition Of The Medical Condition Aci-Jel?Clinical Pharmacology CLINICAL PHARMACOLOGY ACI-JEL (vaginal jelly) acts to restore and maintain normal vaginal acidity through its buffer action.
Drug Description DESCRIPTION ACI-JEL Vaginal Jelly is a bland, non-irritating, water-dispersible, buffered acid jelly for intravaginal use.
ACI-JEL (vaginal jelly) is classified as a Vaginal Therapeutic Jelly.
ACI-JEL (vaginal jelly) contains 0.921% glacial acetic acid (C 2 H 4 O 2 ), 0.025% oxyquinoline sulfate (C 18 H 16 N 2 O 6 S), 0.7% ricinoleic acid (C 18 H 34 O 3 ), and 5% glycerin (C 3 H 8 O 3 ) compounded with tragacanth, acacia, propylparaben, potassium hydroxide, stannous chloride, egg albumen, potassium bitartrate, perfume and purified water.
ACI-JEL (vaginal jelly) is formulated to pH 3.9-4.1.
Indications & Dosage INDICATIONS ACI-JEL (vaginal jelly) is indicated as adjunctive therapy in those cases where restoration and maintenance of vaginal acidity is desirable.
DOSAGE AND ADMINISTRATION The usual dose is one applicatorful, administered intravaginally, morning and evening.
Duration of treatment may be determined by the patient's response to therapy.
HOW SUPPLIED 85g Tube (NDC 0062-5421-01) with ORTHO® Measured-Dose Applicator.
Medication Guide PATIENT INFORMATION No Information Provided.
Overdosage & Contraindications OVERDOSE No Information Provided.
CONTRAINDICATIONS None known.
Side Effects & Drug Interactions Warnings & Precautions WARNINGS No serious adverse reactions or potential safety hazards have been reported with the use of ACI-JEL (vaginal jelly) .
PRECAUTIONS General: No special care is required for the safe and effective use of ACI-JEL (vaginal jelly) .
Drug Interactions: No incidence of drug interactions have been reported with concomitant use of ACI-JEL (vaginal jelly) and any other medications.
Laboratory Tests: The monitoring of vaginal acidity (pH) may be helpful in following the patient's response.
(The normal vaginal pH has been shown to be in the range of 4.0 to 5.0.) Carcinogenesis: No long-term studies in animals have been performed to evaluate carcinogenic potential.
Pregnancy: Pregnancy Category C.
Animal reproduction studies have not been conducted with ACI-JEL (vaginal jelly) .
It is also not known whether ACI-JEL (vaginal jelly) can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.
ACI-JEL (vaginal jelly) should be given to a pregnant woman only if clearly needed.
Nursing Mothers: It is not known whether this drug is excreted in human milk.
Because many drugs are excreted in human milk, caution should be exercised when ACI-JEL (vaginal jelly) is administered to a nursing woman.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Diverticulums, Esophagopharyngeal ‐ A diverticulum at the upper end of the esophagus through the…
- UDPGNAc ‐ Serves as the biological precursor of insect chitin, of muramic…
- Antibodies, Enhancing ‐ Antibodies that inhibit the reaction between antigen and other…
- BFU-E ‐ Committed, erythroid stem cells derived from myeloid stem cells.…
- Chemicals, Agricultural ‐ Chemicals used in agriculture. These include pesticides, fumigants,…
- Particle, Beta ‐ A stream of positive or negative electrons ejected with high…
- Resistance Gene, Multidrug ‐ Genes responsible for multidrug resistance resulting from their…
- Cytokeratin 8 ‐ A class of fibrous proteins or scleroproteins important both…
- Synthetase, S-Adenosylmethionine ‐ An enzyme that catalyzes the synthesis of S-adenosylmethionine…
- AHR-1911 ‐ Proposed topical anti-inflammatory agent that may release histamine…